LONDON--(BUSINESS WIRE)--The global Lennox-Gastaut syndrome (LGS) treatment market is expected to post a CAGR of close to 5% during the period 2019-2023, according to the latest market research report ...

Dublin, July 22, 2025 (GLOBE NEWSWIRE) -- The "Lennox Gastaut Syndrome Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's ...

New York, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Lennox Gastaut Syndrome – Market Insights, Epidemiology, and ...

SAN DIEGO, April 6, 2026 /PRNewswire/ -- The Lennox-Gastaut Syndrome (LGS) Foundation and community are mobilizing Walks for LGS Research around the country this month. This national event unites ...

Please provide your email address to receive an email when new articles are posted on . Clinical outcome assessments currently used for people with Lennox-Gastaut syndrome and Dravet syndrome were ...

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending fenfluramine (Fintepla) for treating seizures associated with Lennox-Gastaut syndrome. The ...

Adding a purified formulation of cannabidiol (CBD; Epidiolex, GW Pharmaceuticals) to standard anticonvulsant therapy significantly reduces the number of drop seizures in children with resistant Lennox ...

Lennox-Gastaut syndrome (LGS) is a rare and severe form of epilepsy, accounting for up to 4 percent of all childhood epilepsy cases. LGS is characterized by three criteria: multiple seizure types, ...

Please provide your email address to receive an email when new articles are posted on . “Most patients with [Lennox-Gastaut syndrome (LGS)] develop between three and five seizure types that wax and ...

Among patients with Lennox-Gastaut syndrome (LGS), the percentage reduction in the frequency of drop seizures is greater with fenfluramine versus placebo, according to a study published online May 2 ...

Lennox-Gastaut syndrome (LGS) is a severe developmental and epileptic encephalopathy characterised by multiple seizure types, a distinctive slow spike-wave electroencephalographic pattern and ...